Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 ,inter alia, to consider and approve Unaudited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Terce Laboratories has informed the BSE that its Board of Directors will meet on Saturday, 8 November 2025 to consider and approve the Unaudited Standalone Financial Results for the second quarter and half year ended 30 September 2025. The results will undergo limited review by the Statutory Auditor before approval. The filing was made on 2 November 2025 under SEBI LODR Regulation 29. The company's trading window has been closed from 1 October 2025 to 10 November 2025 (both days inclusive) for all designated persons, in line with insider trading rules.
This is a standard procedural intimation with no new financial data disclosed. Shareholders should expect the Q2/H1 FY26 results on or shortly after 8 November 2025. The closed trading window restricts insider transactions until results are publicly available.